Evidence map›Paper›PMID 26611762›Full record

ReviewArchivum immunologiae et therapiae experimentalis2016

Neurotrophic Factors and Their Potential Applications in Tissue Regeneration.

Nan Xiao, Quynh-Thu Le

Abstract readReview
In one paragraph

Review in Archivum immunologiae et therapiae experimentalis, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 89 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Optic nerve regeneration: Potential treatment approaches.Current opinion in pharmacology · 2024
    Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Biomaterial-Based bFGF Delivery for Nerve Repair.Oxidative medicine and cellular longevity · 2023
    Review
  15. Neuroprotection and Non-Invasive Brain Stimulation: Facts or Fiction?International journal of molecular sciences · 2022
    Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Nan XiaoDepartment of Biomedical Sciences, Arthur A. Dugoni School of Dentistry, University of the Pacific, San Francisco, CA, USA. nxiao@pacific.edu.ORCID http://orcid.org/0000-0001-7264-3046
Quynh-Thu LeDepartment of Radiation Oncology, School of Medicine, Stanford University, Stanford, CA, USA.
Stanford University · USUniversity of the Pacific · US

Funding

Characterization and Targeting the GDNF and Other Pathways in Salivary Stem CellsR01DE025227 · NIDCR · STANFORD UNIVERSITY · PI LE, QUYNH-THU XUAN, XIAO, NAN · 2015 to 2019
$2.0M
NIDCR NIH HHS R01 DE025227
6 · The paper itself

Abstract

Neurotrophic factors are growth factors that can nourish neurons and promote neuron survival and regeneration. They have been studied as potential drug candidates for treating neurodegenerative diseases. Since their identification, there are more and more evidences to indicate that neurotrophic factors are also expressed in non-neuronal tissues and regulate the survival, anti-inflammation, proliferation and differentiation in these tissues. This mini review summarizes the characteristics of the neurotrophic factors and their potential clinical applications in the regeneration of neuronal and non-neuronal tissues.

Indexed as

Guided Tissue RegenerationAnimalsAnti-Inflammatory AgentsCell DifferentiationCell ProliferationCell SurvivalHumansNerve Growth FactorsNeurodegenerative DiseasesNeuronsAnti-Inflammatory AgentsNerve Growth FactorsNeurotrophic factorTissue regeneration

Identifiers

PMID26611762
PMCPMC4805470
OpenAlexW2180157788

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.